Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
Hypercortisolemia Is Associated with Severity of Bone Loss and Depression in Hypothalamic Amenorrhea and Anorexia Nervosa
Journal of Clinical Endocrinology and Metabolism, 10/21/09
Lawson EA et al. – Anorexia nervosa (AN) and functional hypothalamic amenorrhea (HA) are associated with low bone density, anxiety, and depression. Women with AN and HA have elevated cortisol levels. Significant hypercortisolemia, as in Cushing's disease, causes bone loss. It is unknown whether anxiety and depression and/or cortisol dysregulation contribute to low bone density in AN or HA. Hypercortisolemia is a potential mediator of bone loss and mood disturbance in these disorders.
Today in Endocrinology...keeping you current
Receive free subspecialty "5-minute updates" via email
In patients with type 2 diabetes, perindopril-indapamide had similar relative reductions in mortality and cardiac events regardless of AF status
Evidence-Based Medicine, 12/07/09
Rosiglitazone was non-inferior to metformin plus sulphonylurea for CV events but increased risk of HF and fractures in type 2 diabetes
Evidence-Based Medicine, 12/07/09
Minimally invasive and conventional glucose monitoring did not differ for long-term glycaemic control in insulin-treated diabetes
Evidence-Based Medicine, 12/07/09
Today in Psychiatry...keeping you current
Receive free subspecialty "5-minute updates" via email
What drives referral from primary care physicians to mental health specialists? A randomized trial using actors portraying depressive symptoms
Journal of General Internal Medicine, 12/07/09
Using the patient health questionnaire-9 to measure depression among racially and ethnically diverse primary care patients
Journal of General Internal Medicine, 12/07/09
The effect of mirtazapine add on therapy to risperidone in the treatment of schizophrenia: A double-blind randomized placebo-controlled trial
Schizophrenia Research, 12/07/09
Sponsor
Article Search
Sponsor


See Latest Articles


